Lately, Shanghai FTZ Fund has invested in Shanghai Suxin Biotechnology (iGeneTec Diagnostic), a leading transformation of microfluidic technology focused enterprise.

Shanghai Suxin Biotechnology Company Limited (iGeneTec Diagnostic) focuses on the transformation of microfluidic technology. The company has a wholly owned subsidiary--Shanghai Suchuang Diagnostics Products Company Limited. iGeneTec Diagnostic owns standard biomolecular and immunological laboratory covering more than 3,000 square meters, as well as 10,000 and 100,000 class clean rooms. iGeneTec Diagnostic is a high-tech enterprise integrating R&D, production and sales, and it has passed ISO 13485 quality system certification and CFDA certificates.

Based on molecular detection and microfluidic chip technology, iGeneTec Diagnostic develops multiple series of products which can widely used in clinical diagnosis, food safety test, inspection and quarantine.